BB Biotech AG
Latest statistics and disclosures from BB BIOTECH AG's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CELG, INCY, GILD, Ionis Pharmaceuticals, Radius Health. These five stock positions account for 48.17% of BB BIOTECH AG's total stock portfolio.
- Added to shares of these 9 stocks: Intra Cellular Therapies (+$27.17M), ALXN (+$16.93M), Macrogenics (+$14.03M), Agios Pharmaceuticals (+$8.52M), Ionis Pharmaceuticals (+$7.57M), Tobira Therapeutics Inc Common Stock Usd 0.0001 (+$5.88M), Alder Biopharmaceuticals, VRTX, Sage Therapeutics.
- Started 3 new stock positions in Intra Cellular Therapies, Tobira Therapeutics Inc Common Stock Usd 0.0001, Macrogenics.
- Reduced shares in these 4 stocks: MDVN (-$35.58M), (-$14.23M), Clovis Oncology (-$10.14M), Tesaro (-$6.30M).
- Sold out of its positions in Clovis Oncology, INFI.
- As of June 30, 2016, BB BIOTECH AG has $2.53B in assets under management (AUM). Assets under management grew from a total value of $2.52B to $2.53B.
- Independent of market fluctuations, BB BIOTECH AG was a net buyer by $23.03M worth of stocks in the most recent quarter.
BB BIOTECH AG portfolio companies for June 2016 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Celgene Corporation (CELG) | 14.05 | 3.61M | 98.63 | 118.26 |
| Incyte Corporation (INCY) | 12.12 | 3.84M | 79.98 | 88.43 |
| Gilead Sciences (GILD) | 9.14 | 2.77M | 83.42 | 99.53 |
| Ionis Pharmaceuticals | 6.53 | 7.10M +4.00% | 23.29 | 0.00 |
| Radius Health | 6.33 | 4.36M | 36.75 | 0.00 |
| Neurocrine Biosciences (NBIX) | 5.60 | 3.12M | 45.45 | 40.28 |
| Alexion Pharmaceuticals (ALXN) | 5.44 | 1.18M +14.00% | 116.76 | 179.76 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.81 | 1.42M +3.00% | 86.02 | 123.26 |
| Medivation (MDVN) | 4.74 | 1.99M -22.00% | 60.30 | 127.95 |
| Agios Pharmaceuticals | 3.91 | 2.36M +9.00% | 41.89 | 0.00 |
| Tesaro | 3.83 | 1.15M -6.00% | 84.05 | 0.00 |
| Regeneron Pharmaceuticals (REGN) | 2.83 | 205000 | 349.23 | 427.05 |
| Alnylam Pharmaceuticals (ALNY) | 2.61 | 1.19M | 55.49 | 111.05 |
| Halozyme Therapeutics (HALO) | 2.51 | 7.38M | 8.63 | 15.18 |
| Novavax (NVAX) | 2.39 | 8.33M | 7.27 | 9.03 |
| Juno Therapeutics | 1.98 | 1.30M | 38.44 | 0.00 |
| Alder Biopharmaceuticals | 1.66 | 1.69M +11.00% | 24.97 | 0.00 |
| Kite Pharma | 1.48 | 750000 | 50.00 | 0.00 |
| Intercept Pharmaceuticals In | 1.44 | 255719 | 142.68 | 0.00 |
| Cempra | 1.33 | 2.04M | 16.49 | 0.00 |
| Intra Cellular Therapies | 1.07 | 700000 NEW | 38.82 | 0.00 |
| Sage Therapeutics | 1.01 | 850639 +2.00% | 30.13 | 0.00 |
| Macrogenics | 0.55 | 520000 NEW | 26.99 | 0.00 |
| Puma Biotechnology Inc Common Stock | 0.51 | 431991 | 29.79 | 0.00 |
| Prothena | 0.48 | 350000 | 34.96 | 0.00 |
| Achillion Pharmaceuticals (ACHN) | 0.39 | 1.28M | 7.80 | 11.17 |
| Esperion Therapeutics | 0.39 | 1.01M | 9.88 | 0.00 |
| Ptc Therapeutics I | 0.33 | 1.18M | 7.02 | 0.00 |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.30 | 746824 | 10.31 | 0.00 |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 0.23 | 468000 NEW | 12.56 | 0.00 |
Download CSV 
Past 13F-HR SEC Filings for BB BIOTECH AG
- BB BIOTECH AG 2016 Q1 filed May 12, 2016
- BB BIOTECH AG 2015 Q4 filed Feb. 9, 2016
- BB BIOTECH AG 2015 Q3 filed Nov. 12, 2015
- BB BIOTECH AG 2015 Q2 filed Aug. 12, 2015
- BB BIOTECH AG 2015 Q1 filed May 14, 2015
- BB BIOTECH AG 2014 Q4 filed Feb. 12, 2015
- BB BIOTECH AG 2014 Q3 filed Nov. 13, 2014
- BB BIOTECH AG 2014 Q2 filed Aug. 7, 2014
- BB BIOTECH AG 2014 Q1 filed May 8, 2014
- BB BIOTECH AG 2013 Q4 filed Feb. 12, 2014
- BB BIOTECH AG 2013 Q3 filed Nov. 12, 2013
- BB Biotech AG 2013 Q1 filed May 6, 2013
- BB Biotech AG 2012 Q4 filed Feb. 13, 2013
- BB Biotech AG 2012 Q3 filed Nov. 6, 2012
- BB Biotech AG 2012 Q2 filed Aug. 7, 2012
- BB Biotech AG 2012 Q1 filed May 3, 2012
- BB Biotech AG 2011 Q4 filed Feb. 7, 2012
- BB Biotech AG 2011 Q3 filed Nov. 7, 2011
- BB Biotech AG 2011 Q2 filed Aug. 9, 2011